30-day average of 21 articles · scale −100 to +100
Across 21 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of MetLife news is Somewhat Bullish (+40)
on a scale from −100 to +100.
That is about the same as the previous 30 days (+44).
💸 The company returned approximately $1 billion to shareholders via buybacks and dividends in Q3.
🏦 Net income surged 187% year-over-year to $2.4 billion, or $3.67 per share.
🎯 MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets.
💼 CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy and execution discipline.
📉 Holding-company cash and liquid assets stood at $3.4 billion, within management's target range.
🚀 Broad-based operating momentum supports the case for resilient earnings across divisions.
📈 Bullish signals
📈MetLife reported record Q3 adjusted EPS of $2.85 excluding notable items, a 22% increase from the prior-year quarter and the highest in company history.
💰Revenue increased 12% to $14.1 billion with growth spanning all six business segments, demonstrating broad-based momentum.
📊Adjusted return on equity reached 19.6% excluding notable items, reflecting strong capital efficiency.
💸The company returned approximately $1 billion to shareholders through buybacks and dividends, signaling confidence in its financial position.
🏦Net income surged 187% year-over-year to $2.4 billion, driven by higher variable investment income and favorable underwriting.
🎯MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets, ensuring disciplined capital management.
💼CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy, citing stronger underwriting and volume growth as key drivers.
Article
MetLife Inc. reported record third-quarter adjusted earnings per share of $2.85, excluding notable items, representing a 22% increase from the prior-year quarter. This achievement marks the highest quarterly level in the company's history, driven by broad-based growth across all six business segments. Revenue increased by 12% to $14.1 billion, supported by higher variable investment income, volume growth, and favorable underwriting results.
The company reported net income of $2.4 billion, or $3.67 per share, which was up 187% year-over-year. Adjusted return on equity reached 19.6% excluding notable items, while MetLife confirmed it remains on track to meet its full-year targets for free cash flow and direct expense ratios. Holding-company cash and liquid assets stood at $3.4 billion at quarter-end, aligning with management's target range.
MetLife returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter, highlighting a continued focus on capital returns alongside reinvestment for growth. CEO Michel Khalaf emphasized that the results demonstrate the strength of the New Frontier strategy and the discipline of its execution, citing stronger underwriting and investment returns as key drivers.
The earnings release indicates broad operating momentum rather than growth concentrated in a single division, supporting the case for resilient earnings. MetLife stock traded at 92.45 euros on November 12, 2026, reflecting positive market sentiment following the announcement of these robust financial results and strategic confidence.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
MetLife reported Q1 CY2026 earnings with mixed results relative to analyst expectations, driven primarily by a miss in revenue and book value per share despite a profit beat. The company's non-GAAP profit of $2.42 per share exceeded the consensus estimate of $2.27, representing a 6.6% upside. However, total revenue came in at $19.07 billion, falling short of the estimated $19.41 billion and growing only 1.3% year over year compared to analyst forecasts. Net premiums earned totaled $12.12 billion, slightly beating estimates at $11.65 billion, yet this segment saw a 6.4% year-over-year decline. Consequently, the stock price remained flat at $80.22 immediately following the announcement.
Key financial metrics highlighted significant divergence between earnings and balance sheet performance. Pre-tax profit stood at $1.51 billion with a 7.9% margin, while book value per share dropped to $37.92, missing analyst estimates of $58.37 by 35% and marking a 7.1% year-over-year decline. Management noted that quarters not explicitly detailed in the report were outliers affected by outsized investment gains or losses, which can distort recurring fundamentals. The company's five-year compounded annual revenue growth rate has been sluggish at 3.2%, though performance improved to 4.4% annually over the last two years.
Analyst commentary emphasizes that while earnings per share and premiums earned are crucial for gauging business health, book value per share is a critical indicator of long-term capital growth that is harder to manipulate than EPS. The report notes that Net Premiums Earned accounted for 69.1% of total revenue over the last five years, establishing it as the primary revenue driver. Looking ahead, consensus estimates project a substantial 70.3% increase in book value per share to $58.37 over the next 12 months. However, the company's historical trajectory shows a 12.7% annual decline in book value over the last five years, with a slower 2.5% annual drop over the most recent two-year period before the current reported figures. The overall assessment characterizes the quarter as weaker due to the revenue miss and significant underperformance in book value relative to expectations.
📉 Revenue rose 1.3% but fell short of analyst estimates by 1.7%.
💰 Non-GAAP profit per share beat consensus, though book value missed significantly.
📊 Insurance premiums drive 69.1% of revenue despite a recent annual decline.
📉 MetLife's Q1 CY2026 revenue came in at $19.07 billion, representing a 1.3% year-over-year increase but missing Wall Street estimates by 1.7%.
💰 Non-GAAP profit per share reached $2.42, surpassing analyst consensus estimates by 6.6%.
📜 Net Premiums Earned totaled $12.12 billion, beating expectations with a 4% positive variance despite a year-on-year decline of 6.4%.
💵 Pre-tax profit for the quarter was $1.51 billion, maintaining a pre-tax margin of 7.9%.
📉 Book Value Per Share (BVPS) declined 35% from consensus estimates at $37.92 versus an expected $58.37.
🏛️ Founded in 1868, MetLife is a global financial services company offering insurance, annuities, benefits, and asset management services.
💵 Over the last five years, the company experienced sluggish revenue growth with a compounded annual rate of 3.2%.
📈 Recent two-year annualized revenue growth improved to 4.4%, indicating a stronger recent trend compared to the long-term average.
🎯 Net premiums earned account for 69.1% of total revenue, identifying insurance operations as the primary business driver.
⚠️ The stock remained flat at $80.22 immediately after the earnings report due to mixed results on key metrics.
📊 Book value reflects long-term capital growth and is considered a crucial metric for assessing insurer business quality.
📉 BVPS has seen an annual decline of 12.7% over the past five years, though the recent two-year pace slowed to 2.5%.
🔮 Consensus estimates project a potential 70.3% growth in BVPS over the next 12 months to reach $58.37.
🤖 Analysts view investment and fee income as more volatile than core insurance operations, focusing heavily on premium growth.
⚠️ The quarter was characterized as weaker overall because revenue and book value missed targets despite EPS beats.
Bullish Signals
MetLife non-GAAP profit of $2.42 beat estimates by 6.6%.
Adjusted EPS reached $2.42, surpassing analyst expectations of $2.27.
Net premiums earned of $12.12B exceeded the analyst estimate.
MetLife's annualized revenue growth accelerated to 4.4% recently.
Consensus projects MetLife BVPS to grow 70.3% to $58.37.
Risk Factors
Revenue missed estimates by $0.34B with only 1.3% YoY growth.
BVPS significantly missed expectations at $37.92 versus $58.37 target.
Core insurance Net Premiums Earned declined 4% year-on-year.
Five-year revenue growth of 3.2% trailed industry benchmarks.
BVPS eroded 12.7% annually over the last five years.
Bullish Signals
MetLife's non-GAAP profit of $2.42 per share beat analysts' consensus estimates by 6.6%.
Adjusted EPS reached $2.42, surpassing analyst expectations of $2.27.
Net premiums earned of $12.12 billion exceeded the analyst estimate of $11.65 billion.
MetLife's annualized revenue growth accelerated to 4.4% over the last two years, which is above its five-year trend.
Consensus estimates project MetLife's Book Value per Share (BVPS) to grow by an elite 70.3% over the next 12 months to $58.37.
MetLife provides insurance, annuities, employee benefits, and asset management services to a global client base.
Risk Factors
MetLife's revenue fell short of Wall Street estimates at $19.07 billion, missing the consensus by $0.34 billion and growing only 1.3% year-over-year.
Book Value Per Share (BVPS) suffered a significant miss against analyst expectations of $58.37, closing at $37.92 due to a 7.1% decline year-over-year that significantly trailed the projected growth.
The core insurance business is lagging with Net Premiums Earned declining 4% year-on-year, raising concerns about the company's ability to grow its primary revenue stream.
Over the past five years, MetLife's compounded annual revenue growth rate was merely 3.2%, which fell short of the broader insurance sector benchmark.
The company's long-term BVPS has eroded at a 12.7% annual clip over the last five years, indicating persistent challenges in capital growth despite recent recovery.
The article provides an analysis of Wall Street analyst estimates for MetLife (MET) ahead of its quarterly earnings report, projecting EPS of $2.23 per share, a 13.8% year-over-year increase, and revenues of $19.2 billion, representing a 2% rise from the prior quarter. Recent data indicates that the consensus EPS estimate has been revised downward by 1.2% over the past 30 days, highlighting the dynamic nature of analyst projections which are often correlated with short-term stock price movements. Beyond aggregate figures, detailed breakdowns reveal that revenue premiums are estimated at $11.49 billion (down -2%), while other revenues are projected at $705.48 million (+2.7%). Key segment estimates show significant growth in net investment income at $5.68 billion (+16.3%) and a substantial increase of 1,425.8% in adjusted corporate revenue. Regional analysis predicts Latin America total adjusted revenue of $2.17 billion (+13.2%), Asia reaching $3.14 billion (+8.9%), and EMEA at $807.11 million (+11.2%).
MetLife's stock has performed strongly, with shares gaining 13.3% over the past month compared to the Zacks S&P 500 composite's 10.5% gain, though it currently carries a Zacks Rank #3 (Hold), suggesting an expectation to mirror overall market performance in the near future. The analysis emphasizes that while consensus estimates for EPS and total revenue provide a baseline, examining specific line items such as universal life fees ($1.29 billion) and segmented investment incomes offers deeper insight into business health. For instance, Latin America net investment income is forecast at $456.73 million (+12.2%), Asia net investment income at $1.41 billion (+16.8%), and EMEA net investment income at $66.84 million (+15.2%). Other revenue streams also show growth, with Asia other revenues estimated at $19.43 million (+29.5%) and universal life fees showing a 5.2% increase year-over-year.
Notably, the provided text includes a segment on Uber Technologies (UBER) after the MetLife analysis, forecasting Uber's quarterly earnings at $0.71 per share, which represents a 14.5% year-over-year decline, and revenues of $13.27 billion, a 15% increase. Similar to the MetLife section, this part notes a 1% downward revision in Uber's consensus EPS over the last 30 days. Metric breakdowns for Uber indicate mobility revenue of $6.99 billion (+7.6%), freight revenue of $1.27 billion (+0.8%), and delivery revenue of $4.92 billion (+30.2%). Geographic estimates for Uber show Latin America revenue at $873.65 million (+21.9%) and United States and Canada revenue reaching $6.87 billion (+10.4%), with the analysis noting that the Asia Pacific revenue figure was cut off in the source text.
📈 Analysts project MetLife quarterly EPS of $2.23, a 13.8% year-over-year increase.
💰 Revenue estimates total $19.2 billion, though 'Revenue-Premiums' are expected to drop 2%.
🌍 Net investment income across all regions is forecast to surge significantly year-over-year.
🚀 Shares rose 13.3% last month, outperforming the S&P 500 despite a Hold rating.
🏢 Wall Street analysts project MetLife (MET) quarterly earnings at $2.23 per share, representing a 13.8% year-over-year increase.
💰 Consensus revenue estimates for MetLife stand at $19.2 billion, reflecting a 2% growth compared to the prior-year quarter.
📉 The consensus EPS estimate has been revised downward by 1.2% over the past 30 days as analysts reassess forecasts.
📈 Analysts expect MetLife's 'Revenue-Premiums' to reach $11.49 billion, marking a 2% decline from the year-ago quarter.
💵 'Revenue-Other Revenues' are projected at $705.48 million, indicating a 2.7% year-over-year increase.
💼 Policy fees related to universal life and investment-type products are estimated at $1.29 billion, up 5.2% year-over-year.
🌍 Net investment income is forecasted to hit $5.68 billion, driven by a strong 16.3% year-over-year increase.
📜 Adjusted Revenue for Latin America is expected to reach $2.17 billion, showing a 13.2% year-over-year gain.
🏢 Corporate & other net investment income is predicted at $1.08 billion, representing a massive 1425.8% increase from the prior quarter.
🌍 EMEA adjusted revenue totals are projected at $807.11 million, up 11.2% year-over-year.
🌏 Asia total adjusted revenue is estimated at $3.14 billion, reflecting an 8.9% year-over-year increase.
💰 Asia net investment income specifically is forecasted at $1.41 billion, a 16.8% rise from the prior-year quarter.
🌍 EMEA net investment income is expected to reach $66.84 million, up 15.2% year-over-year.
💵 Latin America net investment income is projected at $456.73 million, indicating a 12.2% year-over-year increase.
🚀 MetLife shares have gained 13.3% over the past month, outperforming the S&P 500 composite's 10.5% gain.
📊 MET currently holds a Zacks Rank #3 (Hold), suggesting it may mirror overall market performance in the near term.
Bullish Signals
MetLife analysts project quarterly earnings of $2.23 per share, representing an impressive 13.8% year-over-year increase.
Revenue is expected to reach $19.2 billion, marking a 2% growth from the same quarter last year.
'Net investment income' is forecasted to surge by 16.3% year over year to $5.68 billion.
'Adjusted Revenue- Asia- Net investment income' shows robust growth with a projected increase of +16.8% year over year.
'Total Adjusted Revenue- Latin America' is estimated to grow by +13.2%, reaching $2.17 billion.
'Adjusted Revenue- Corporate & other- Net investment income' displays exceptional momentum with a year-over-year change of +1425.8%.
MetLife shares have delivered +13.3% returns over the past month, outperforming the S&P 500 composite's +10.5% gain.
Multiple revenue segments demonstrate strong double-digit growth, including 'Revenue- Universal life and investment-type product policy fees' at +5.2%.
Risk Factors
Wall Street analysts have collectively revised their EPS consensus estimates downward by 1.2% for MetLife (MET) over the past 30 days, signaling a bearish reassessment of the company's earnings potential before its quarterly report.
Analysts project that 'Revenue- Premiums' will decline by 2% year-over-year to $11.49 billion, indicating weakness in one of the key revenue streams for MetLife.
MetLife's stock is currently assigned a Zacks Rank #3 (Hold), suggesting analysts do not see strong near-term upside and expect the stock to merely mirror overall market performance rather than outperform.
The significant 495% year-over-year increase in 'Adjusted Revenue- Corporate & other- Net investment income' ($1.08 billion) may mask underlying operational struggles or one-off items that could inflate current earnings estimates without reflecting sustainable growth.
Sun Life Financial Inc. has reached a settlement in principle to resolve a long-running class action lawsuit regarding individual life insurance policies sold by Metropolitan Life Insurance Company (MetLife) during the 1980s and 1990s. The proposed agreement would see Sun Life provide up to $213.5 million in settlement value to eligible policyholders, pending final court approval. Upon approval, Sun Life expects to record an estimated after-tax charge of approximately $145 million against its first quarter of 2026 reported net income. This matter relates specifically to the interpretation of policy language in historic MetLife life insurance policies that Sun Life inherited through past Canadian acquisitions, a legal issue explicitly stated by the company as not involving any policies sold under its own brand.
The class action litigation has been ongoing for years and was recently disclosed in Note 22G of Sun Life's 2025 Annual Consolidated Financial Statements. Under the terms of a previous indemnity arrangement where MetLife provided coverage for these legacy policies, Sun Life plans to seek full recourse from MetLife for the settlement costs should the deal receive court approval. If approved, the agreement would bring finality to this long-standing dispute and provide certainty for affected policyholders. As of December 31, 2025, Sun Life reported assets under management totaling $1.60 trillion across operations in Canada, the United States, Europe, and Asia-Pacific, with shares traded on the Toronto, New York, and Philippine stock exchanges. The settlement process and subsequent notice to class members remain subject to judicial approval before becoming effective.
🏦 Sun Life settles historic MetLife policy lawsuits in principle.
💰 Up to $213.5 million will be paid to eligible claimants.
📉 An estimated $145M after-tax charge impacts Q1 2026 income.
⚖️ Costs target legacy acquisitions, not current Sun Life products.
🔄 Full recourse sought from MetLife for settlement expenses.
🏦 Sun Life has reached a settlement in principle to resolve a class action lawsuit regarding historic MetLife life insurance policies sold in the 1980s and 1990s.
💰 The proposed deal involves providing up to $213.5 million in settlement value to eligible policyholders, subject to final court approval.
📉 Sun Life expects to record an estimated after-tax charge of approximately $145 million against its Q1 2026 reported net income.
⚖️ The litigation concerns the interpretation of legacy policy language inherited through past Canadian acquisitions rather than current Sun Life products.
🔍 This matter was previously disclosed in Note 22G of Sun Life's 2025 Annual Consolidated Financial Statements.
🔄 MetLife provided an indemnity for these legacy policies, and Sun Life plans to seek full recourse from MetLife to recover settlement costs if approved.
✅ Finalizing the agreement will bring closure to a long-standing legal dispute and provide certainty for affected policyholders.
🕊️ The settlement process remains pending court approval before any payments are made or charges recorded.
Bullish Signals
Sun Life has reached a settlement in principle that will provide up to $213.5 million in settlement value to eligible policyholders, subject to court approval.
MetLife is providing an indemnity relating to these legacy policies, allowing Sun Life to seek full recourse and effectively attempt to recover the settlement costs.
The agreement would bring finality to a long-standing legal dispute, providing certainty for affected policyholders.
Sun Life inherited these historic MetLife policies through past Canadian acquisitions, but the company emphasized that the matter does not involve any policies or products it has sold under its own brand.
Risk Factors
Sun Life expects to record an estimated after-tax charge of approximately $145 million to its Q1 2026 reported net income, which will negatively impact earnings.
The company must provide up to $213.5 million in settlement value to eligible policyholders if the court approves the deal, representing a significant cash outflow.
If the settlement is approved by the court, Sun Life only plans to seek full recourse from MetLife under the indemnity arrangement, implying potential risk of insufficient recovery.
The litigation concerns historic MetLife policies sold in the 1980s and 1990s that Sun Life inherited, suggesting long-tail liability risks associated with legacy acquisitions.
The proposed settlement remains subject to court approval, creating uncertainty regarding the timing and finality of this significant financial event.
The provided text appears to be a webpage scrape or raw HTML dump from Moneycontrol.com rather than a news article with a coherent narrative about "met." The content includes navigational elements, advertisements for stocks like Adani Power and Ola Electric, cryptocurrency promotion banners, insurance company lists, and website verification messages. While it mentions specific NAV (Net Asset Value) data for the "PNB MetLife - Met Smart Plus Accelerator" plan—citing Rs 80.6507 as of April 29, 2025, and a projected or different figure of Rs 80.9686 for April 29, 2026—it does not offer a descriptive summary, analysis, or news story regarding the plan's performance, strategy, or implications beyond these raw data points. The text functions primarily as an interface listing for an equity-linked insurance product rather than a financial news report. Consequently, a meaningful summary of news content cannot be constructed from this source material.
SKIP
📈 NAV projected to rise from Rs 80.65 to Rs 80.97 by April 2026.
📉 Fund operates under PNB MetLife with historical data tracing back to 2000.
⚠ Moneymoney warns against scams promising assured returns and demands official verification.
📈 The Net Asset Value (NAV) of PNB MetLife's Met Smart Plus Accelerator fund was recorded at Rs 80.6507 as of April 29, 2025.
📉 The projected NAV for the same fund is estimated to reach Rs 80.9686 by April 29, 2026.
💼 PNB MetLife operates this accelerator fund under its Life Insurance subsidiary, offering a product within the mutual fund or unit-linked insurance sector.
📊 The platform provides tools for users to calculate returns and analyze performance data over historical time periods ranging from 2000 to 2026.
⚠️ Moneycontrol issued a specific warning against individuals falsely claiming affiliation to solicit funds with promises of assured returns.
🔒 Users are advised to verify their accounts through official channels if approached by such unauthorized representatives for investment purposes.
📌 The article page also lists other top Indian stocks and insurance companies as related financial instruments but does not provide detailed analysis on them.
💻 A copyright notice confirms that all content belongs to Network18 Media & Investments Limited and reproduction is prohibited without permission.
Bullish Signals
PNB MetLife Smart Plus NAV grew from Rs 80.65 to Rs 80.97.
Backed by powerful trader and investor packs for diverse needs.
Risk Factors
NAV grew marginally from Rs 80.65 to 80.97.
0.4% annualized return barely justifies high expense ratio.
The PNB MetLife - Met Smart Plus Accelerator unit has demonstrated positive NAV growth, increasing from Rs 80.6507 as on 29-Apr-2025 to Rs 80.9686 as on 29-Apr-2026.
The product is backed by a powerful mix of both trader and investor packs, designed to cater to diverse investment needs through timely expert advice.
Risk Factors
The fund's Net Asset Value (NAV) has grown only marginally from Rs 80.6507 in April 2025 to Rs 80.9686 by April 2026, indicating very poor performance over the one-year period.
An annualized return of approximately 0.4% suggests the fund is generating returns barely above or below the risk-free rate, failing to justify its expense ratio.
The product description emphasizes 'trader and investor packs' for 'volatile markets', which introduces significant downside risk for conservative investors seeking stability.
MetLife announced on Tuesday that its board of directors approved an increase to the company's quarterly common stock dividend by 4.4%, raising the payout from 56.75 cents to 59.25 cents per share. This adjustment brings the equivalent annualized dividend to $2.37 per share, based on the company's latest closing stock price of $78.28. Consequently, the new dividend yield is calculated at 3%.
This move continues MetLife's long-term trend of consistent growth in shareholder returns, as the insurance giant has raised its common stock quarterly dividend at a compound annual growth rate of 8.1% since 2011. The updated dividend is scheduled to be payable on June 9 to shareholders who are recorded on May 12.
The information was published by MarketWire via Dow Jones Newswires on April 28, 2026, noting that the data provided reflects U.S. stock quotes through Nasdaq with intraday data delayed by at least 15 minutes or according to exchange requirements.
📈 MetLife raises quarterly dividend 4.4% to 59.25 cents.
💰 Annualized rate reaches $2.37 with a ~3% yield.
📉 Dividend grew 8.1% annually since 2011.
📅 Record date is May 12 for June 9 payment.
📈 MetLife increased its quarterly dividend by 4.4% to 59.25 cents per share.
💰 This adjustment raises the company's annualized dividend rate to $2.37 per share.
📊 The current yield stands at approximately 3% based on the latest closing stock price of $78.28.
📉 MetLife has grown its quarterly dividend by a compound annual growth rate of 8.1% since 2011.
📅 Shareholders must be on record by May 12 to receive the payment scheduled for June 9.
Bullish Signals
MetLife raised quarterly dividend 4.4% to 59.25 cents.
Annualized yield is 3% at a $78.28 closing price.
Quarterly dividends grew 8.1% annually since 2011.
Management shows confidence with increased capital returns.
Bullish Signals
MetLife raised its quarterly dividend by 4.4% to 59.25 cents a share, from 56.75 cents.
The annualized dividend now stands at $2.37 per share, offering a 3% yield based on the latest closing price of $78.28.
The company has demonstrated consistent growth by increasing its quarterly dividend at an 8.1% compound annual growth rate since 2011.
This positive financial signal indicates strong management confidence and capital returns to shareholders.
Risk Factors
The article reports an increase in dividends, which does not contain any specific negative aspects, risks, or downside catalysts related to the provided content.
New York-based MetLife, Inc. (MET) is preparing to announce its fiscal first-quarter earnings for 2026, with analysts projecting the company will beat consensus estimates based on recent performance trends. MET is a global financial services provider operating across insurance, annuities, employee benefits, and asset management, with a current market capitalization of $46.4 billion. Regarding the upcoming Q1 report, Wall Street expects the company to report a diluted profit of $2.21 per share, representing a 12.8% increase from $1.96 per share in the same quarter last year. Over the past four quarters prior to this announcement, MetLife has consistently beaten estimates in two instances while missing forecasts on two others, suggesting a volatile but generally positive analyst reception.
For full-year outlooks, analysts anticipate MET will report earnings per share (EPS) of $9.86 for the current fiscal year, which would mark an 10.9% rise from the $8.89 reported in fiscal 2025. Growth is projected to continue into the next fiscal period, with EPS expected to reach $10.99 in fiscal 2027, reflecting an 11.5% year-over-year increase. The company's stock has historically underperformed broader market indices, posting only an 8.7% gain over the past 52 weeks compared to the S&P 500 Index’s 36.1% rally and the State Street Financial Select Sector SPDR ETF’s (XLF) 16.6% return. Most recently, following its Q4 results on February 4, shares rose 1.4% after adjusted EPS of $2.49 and a 27.6% revenue increase to $23.8 billion were reported.
Investor sentiment remains favorable, with MET receiving an overall "Moderate Buy" rating from the analyst community. Of the 19 analysts covering the stock, 11 maintain a "Strong Buy" stance, while one suggests a "Moderate Buy" and seven recommend a "Hold." The average analyst price target is set at $91.44, which implies approximately 23% upside from current trading levels. Beyond earnings, other market updates include potential calendar reminders for April regarding major consumer stocks and commentary on housing redesigns by Mark Cuban, though these are tangential to MetLife's specific financial performance.
📈 MetLife (MET) Q1 2026 diluted EPS estimated at $2.21, a 12.8% year-over-year increase.
💰 Full-year analysts project $9.86 EPS for 2026 and $10.99 for 2027 with double-digit growth.
⚠️ Stock gained only 8.7% over S&P 500's 36.1% gain during past 52 weeks.
🏦 Market cap stands at $46.4 billion with average price target of $91.44 (23% upside).
⚖️ Analyst sentiment is bullish with split ratings including multiple strong buys and seven holds.
📈 MetLife (MET) is expected to report fiscal Q1 2026 earnings with diluted EPS of $2.21, representing a 12.8% increase from the prior year quarter.
💰 Full-year analysts estimate MET will post $9.86 EPS in fiscal 2026 and $10.99 EPS for fiscal 2027, reflecting double-digit projected growth.
📊 Previous Q4 2025 results showed adjusted EPS of $2.49 and revenue growth of 27.6% to $23.8 billion following the Feb. 4 announcement.
📉 MET stock has underperformed the S&P 500 and Financial Select Sector ETF over the past 52 weeks, gaining only 8.7% versus 36.1% and 16.6% respectively.
🏦 The company provides insurance, annuities, employee benefits, and asset management services globally with a market cap of $46.4 billion.
⚖️ Analyst sentiment is generally bullish with an average price target of $91.44, implying roughly 23% upside from current levels.
📝 Of 19 analysts covering MET, the ratings are split between multiple strong buy recommendations and seven holds.
❗ Previous quarters show mixed analyst performance records, with MET beating consensus in two quarters while missing forecasts in two others.
Bullish Signals
Profit expected to rise 12.8% YoY to $2.21 per share in Q1 2026.
Full-year EPS forecast increases 10.9% to $9.86, up from fiscal 2025 levels.
Long-term growth visible with EPS projected at $10.99 by fiscal 2027.
Recent Q4 adjusted EPS jumped 19.1% YoY to $2.49 with revenue up 27.6%.
Analysts see 23% upside potential with average price target of $91.44.
Majority of 19 analysts advise 'Strong Buy' rating for MetLife stock.
Risk Factors
MET stock gained only 8.7% versus S&P 500's 36.1% in 52 weeks.
Stock lagged XLF ETF's 16.6% returns over the last year.
Mixed analyst consensus: seven rate as Hold with lingering uncertainty.
Inconsistent performance: beat forecasts only two of four last quarters.
Bullish Signals
MetLife expects fiscal first-quarter 2026 profit of $2.21 per share, representing a strong 12.8% increase from $1.96 per share in the same quarter last year.
For the full fiscal year, analysts forecast MET to report EPS of $9.86, which is up 10.9% from $8.89 in fiscal 2025.
Long-term growth is visible with EPS projected to rise 11.5% year over year to $10.99 in fiscal 2027.
Recent Q4 performance demonstrated robust momentum, with adjusted EPS jumping 19.1% year over year to $2.49 and revenue surging 27.6% to $23.8 billion.
The analyst consensus is moderately bullish with an average price target of $91.44, indicating a potential upside of 23% from current levels.
Of the 19 analysts covering MetLife, 11 advise a 'Strong Buy' rating and only 7 give a 'Hold', reflecting positive sentiment.
Risk Factors
MET stock has underperformed the S&P 500 Index's 36.1% gains over the past 52 weeks, rising only 8.7% during the same period.
The stock also lagged behind the State Street Financial Select Sector SPDR ETF's (XLF) 16.6% returns over the last year.
Analyst consensus is mixed with seven analysts rating the stock a 'Hold,' signaling lingering uncertainty despite overall bullish sentiment.
Historical performance shows inconsistency, with the company beating forecasts in only two of its last four quarters while missing on two others.
MetLife's chief market strategist Drew Matus joined CNBC's "Money Movers" to discuss the implications of recent jobs data on Federal Reserve policy. Matus argued that the latest employment figures significantly constrain the Fed's ability to adjust interest rates, making a market reaction more predictable and difficult than previous expectations suggested. He emphasized that the data is creating a rigid framework for central bank decision-making, limiting how quickly or aggressively the Fed can pivot its monetary stance based on traditional economic indicators.
The segment highlighted broader market sentiment regarding inflation and rate cuts, with OnePoint BFG's Peter Boockvar forecasting 3-4% inflation through year-end and expecting only one "symbolic" rate cut in that timeframe. Morgan Stanley CIO Mike Wilson noted that the current market playbook now resembles pre-war dynamics, suggesting a shift in how investors are pricing economic outcomes relative to geopolitical and domestic stability factors. Meanwhile, TWG Global’s Amos Hochstein commented on international tensions, stating it is "fantasy" to believe Iran will relinquish control over the Strait of Hormuz, underscoring persistent geopolitical risks affecting global trade flows.
Other key themes from the episode included domestic policy efforts and economic pain points. Representative Brian Fitzpatrick spoke on bipartisan initiatives aimed at funding the Department of Homeland Security, reflecting a focus on legislative solutions for border and security challenges. Additionally, CFR's Michael Froman assessed the situation involving Iran, noting that the U.S. underestimated "how much pain" Tehran is willing to endure in potential conflicts. These perspectives collectively paint a complex economic landscape where strong labor data restricts policy flexibility while external threats and inflation expectations continue to shape market strategy for 2026.
📉 Strong jobs data limits Fed interest rate adjustment flexibility.
🤔 Morgan Stanley sees current markets mirroring pre-war conditions.
⚠️ Iran is unlikely to relinquish Strait of Hormuz control.
📊 Peter Boockvar forecasts 3-4% inflation and one rate cut.
🗳️ Bipartisan efforts underway to fund Department of Homeland Security.
📉 Jobs data has limited the Federal Reserve's ability to adjust interest rates effectively.
🤔 Drew Matus from MetLife notes that strong employment figures complicate Fed reaction plans.
💼 Morgan Stanley CIO Mike Wilson suggests the current market playbook mirrors pre-war conditions.
⚠️ Amos Hochstein warns it is unrealistic to expect Iran to relinquish control of the Strait.
📊 Peter Boockvar forecasts 3-4% inflation and a single symbolic rate cut by year-end.
🗳️ Representative Brian Fitzpatrick discussed bipartisan efforts to fund the Department of Homeland Security.
⚔️ Michael Froman states the U.S. underestimated Iran's willingness to endure significant pain.
Bullish Signals
MetLife: Strong jobs data limits Fed's quick rate cuts. Stability expected.
Morgan Stanley: Markets resemble pre-war levels, signaling resilience.
OnePoint BFG: One symbolic rate cut anticipated despite inflation.
Market depends on 3-4% inflation and one symbolic rate cut.
Bullish Signals
MetLife's Drew Matus highlights that robust jobs data limits the Federal Reserve's ability to cut rates quickly, suggesting a stable economic environment.
Morgan Stanley CIO Mike Wilson compares current market conditions to pre-war levels, indicating resilience and familiarity for investors.
OnePoint BFG's Peter Boockvar expects one 'symbolic' rate cut by year-end despite 3-4% inflation, showing potential policy support for growth.
Rep. Brian Fitzpatrick is engaged in bipartisan efforts to fund the Department of Homeland Security, fostering political stability.
Risk Factors
The jobs data makes it hard for the Fed to react.
The market outlook relies on expectations of only 3-4% inflation, with investors expecting merely one 'symbolic' rate cut by year-end.
MetLife (MET) has recently attracted investor attention following share price volatility, recording a 0.6% decline over the past day and a modest gain over the past week. However, broader performance metrics indicate mixed short-term trends, with both the 90-day and year-to-date share price returns showing an 11.95% decline in contrast to a stronger 3-year total shareholder return of 31.37%. Currently trading at $70.72, the stock presents an indicated intrinsic value discount of 51.65% against an average analyst target price of $90.50, leading Simply Wall St to frame the current valuation primarily as earnings-driven rather than sentiment-driven.
The analysis suggests MetLife is undervalued with a fair value target of $90.50, supported by strong, sustained premium and sales growth in high-potential international markets including Asia, Latin America, and EMEA. This long-term growth potential is positioned to capitalize on growing middle-class wealth and increased insurance penetration, which supports robust revenue and top-line expansion. The fair value narrative relies on a detailed playbook blending steady top-line expansion, firmer profit margins, and disciplined capital use through future buybacks rather than aggressive blue sky forecasts.
Despite the undervalued stance, the investment thesis carries specific risks that could alter the valuation dynamics. The primary concerns include interest rate volatility that could pressure investment margins, as well as commercial mortgage loan losses and reserve builds that may strain earnings and capital reserves. Simply Wall St advises investors to weigh these factors carefully and consult a full narrative to understand the forecasts behind the fair value calculation, noting that this analysis uses historical data and analyst forecasts without constituting financial advice or accounting for the latest price-sensitive announcements.
💰 Analyst target price of $90.50 suggests current market discount.
⚠️ Key risks include interest rate volatility and mortgage loan losses.
📉 MetLife (MET) stock declined 0.6% over the past day and gained slightly over the past week amid recent volatility.
⚠️ The stock has experienced weak share price returns over recent months with a 11.95% drop in the past 90 days and year-to-date.
📈 Long-term performance remains positive with a 3-year total shareholder return of 31.37%.
💰 MetLife is trading at $70.72 against an indicated intrinsic value discount of 51.65%.
🎯 The stock trades below the average analyst target price of $90.50.
🌏 Strategic growth opportunities exist in high-potential international markets like Asia, Latin America, and EMEA.
💵 The fair value model assumes disciplined capital use, ongoing buybacks, and steady top-line expansion rather than aggressive forecasts.
⚠️ Risks include interest rate volatility impacting investment margins and potential commercial mortgage loan losses.
📊 Simply Wall St's analysis concludes MetLife is currently undervalued with a fair value of $90.50.
💡 Investors are encouraged to scan broader screens for 20 founder-led companies, 62 high quality undervalued stocks, and 12 dividend fortresses.
📝 This article serves as general commentary based on historical data and analyst forecasts and is not financial advice.
Bullish Signals
MetLife's 3-year TSR of 31.4% highlights strong underlying value despite recent decline.
Stock trades at a 51.65% discount to $90.50 fair value, offering a compelling buy.
Premium and sales growth in Asia, Latin America, and EMEA support long-term revenue expansion.
Disciplined capital use and buybacks will drive top line growth and firmer margins.
Risk Factors
Input appears empty or invalid. Please provide actual content to summarize.
Bullish Signals
MetLife's 3-year total shareholder return of 31.37% significantly outperforms its recent short-term decline, highlighting strong underlying long-term value.
The stock trades at an indicated intrinsic value discount of 51.65% below a fair value target of $90.50, presenting a compelling buying opportunity.
Strong sustained premium and sales growth in high-potential international markets including Asia, Latin America, and EMEA positions the company for robust long-term revenue expansion.
The company's playbook assumes disciplined capital use and ongoing buybacks to support steady top line expansion and firmer profit margins.
MetLife Inc. (MET) saw its shares rise 1.03% to close at $69.89 on Tuesday, continuing a streak of two consecutive days of gains for the insurer. However, this performance was overshadowed by an underwhelming comparison against rival companies and the broader market context, which remained weak throughout the day. The trading session proved rough overall for equity markets, with the S&P 500 Index (SPX) declining 0.37% to finish at 6,556.37, while the Dow Jones Industrial Average (DJIA) slipped 0.18% to settle at 46,124.06. Despite the challenging environment for the general market, MetLife managed to post gains, though they lagged behind its competitors in relative terms.
The article highlights that while MetLife's stock advanced, it was part of an all-around rough trading session characterized by declines in major benchmarks. MarketWatch notes that this report is supported by world-class market data from Dow Jones and FactSet, with content automation assistance provided by Automated Insights. The summary emphasizes the specific performance metrics for the day, including the precise closing price of MetLife at $69.89 and the percentage increase of 1.03%.
No further operational details or financial statements are provided in this brief update beyond the daily stock movement and broader market index changes. The text includes standard data disclaimers from MarketWatch, noting that intraday data is delayed by at least 15 minutes or subject to exchange requirements, and historical end-of-day data is sourced from FACTSET. All quotes reflect trades reported through Nasdaq in local exchange time, underscoring the limitations of the real-time data used for the report. The article is published on March 24, 2026, at 4:51 p.m. ET, and carries copyright ownership by MarketWatch, Inc.
🔁 This marks MetLife's second consecutive day of gains.
📉 MetLife Inc. (MET) shares rose 1.03% to $69.89 on Tuesday, outperforming the broader market decline.
📊 Despite MET's gains, the stock underperformed competitors as the S&P 500 fell 0.37% and the Dow Jones Industrial Average dropped 0.18%.
📈 This marks MetLife's second consecutive day of positive trading activity.
Bullish Signals
MetLife Inc. (MET) shares advanced 1.03% to $69.89 on Tuesday, posting gains even as the broader market fell.
This marks the stock's second consecutive day of gains, demonstrating resilience despite a rough trading session for the S&P 500 and Dow Jones Industrial Average.
Risk Factors
MetLife stock advanced 1.03% on Tuesday, but still underperformed relative to competitors despite overall market gains.
Shares traded at $69.89 during a rough trading session where the broader market saw declines, indicating weaker sentiment compared to peers.
Despite two consecutive days of gains, the company failed to capture significant upside during an otherwise difficult market environment, suggesting limited investor enthusiasm.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)